From GlobeNewswire: 2025-05-08 14:54:00

A recent study by BCC Research projects the global tissue diagnostics market to increase from $8.9 billion in 2024 to $12.4 billion by 2029, with a CAGR of 7.0%. The report covers market dynamics, product types, and regional analyses, focusing on tissue sample-based tests for diseases like cancer.

Precision medicine emphasizes accurate disease diagnosis, especially for cancer, driving technological advancements in digital pathology and AI for improved diagnostic accuracy. Early cancer detection is vital for better treatment outcomes, and the insights from the report aid in resource allocation and strategic decision-making for cancer management.

Key market drivers include the rising incidence of cancer cases, the importance of early cancer testing, and the impact of an aging population on increasing cancer cases. Companion diagnostics play a crucial role in tailoring cancer treatments, while public awareness campaigns promote early medical check-ups for better cancer prognosis.

The tissue diagnostics market is projected to reach $12.4 billion by 2029, with a CAGR of 7.0%. Key factors driving growth include the increasing demand for advanced diagnostic solutions due to rising cancer cases and the importance of companion diagnostics for personalized cancer treatments. North America holds the largest market share.

Companion diagnostics personalize cancer treatments based on individual patient profiles, revolutionizing therapy targeting and outcomes. Digital pathology transforms glass slides into digital images, enhancing diagnostic accuracy and efficiency. Market leaders in tissue diagnostics include Abbott, Agilent Technologies, and Roche, among others.



Read more at GlobeNewswire: Tissue Diagnostics Market to Reach $12.4 Billion by 2029,